Kevin Laliberte
Plus aucun poste en cours
Profil
Kevin Laliberte served as the Executive Vice President-Product Strategy at Axsome Therapeutics, Inc. and as the Senior Vice President-Product Development at Dova Pharmaceuticals, Inc. He holds a doctorate degree from the University of Michigan.
Anciens postes connus de Kevin Laliberte
| Sociétés | Poste | Fin |
|---|---|---|
| AXSOME THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| DOVA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Kevin Laliberte
| University of Michigan | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AXSOME THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
